Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a36c66685971b78daf233b5999ead4c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b5454abd09f216530c44daae0e81afa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39591 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89c85ef75e2f8960de26f1fa88143321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce4164ccb87b13e7eb08fbc4a5630c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e36578bab19e0c8f75c6f783b0d89f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96a48c789d36c83bb39c646cb7acc04a |
publicationDate |
2021-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-112021010414-A2 |
titleOfInvention |
PHARMACEUTICAL COMPOSITION COMPRISING A CD40 ANTIBODY, METHOD FOR PREPARING A LYOPHILIZED PREPARATION, LYOPHILIZED PREPARATION, USE THEREOF AND PRODUCT INCLUDING A CONTAINER CONTAINING THEM |
abstract |
PHARMACEUTICAL COMPOSITION COMPRISING A CD40 ANTIBODY, METHOD FOR PREPARING A LYOPHILIZED PREPARATION, LYOPHILIZED PREPARATION, USE THEREOF AND PRODUCT INCLUDING A CONTAINER CONTAINING THEM. The present invention provides a pharmaceutical composition comprising a CD40 antibody or an antigen-binding fragment thereof and an acetic acid-sodium acetate buffer solution, and a use thereof. The pharmaceutical composition may additionally contain sugar, a non-ionic surfactant and other excipients. The pharmaceutical composition of the present invention shows good antibody stability. |
priorityDate |
2018-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |